Compositions, methods, and systems for the synthesis and use of imaging agents
View Patent ↗The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in 18 F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.
1. A composition comprising a compound comprising formula (II):
or a salt, free base, or combination thereof, wherein:
R 1 is alkyl, haloalkyl, alkynyl, alkenyl, heteroalkyl, cycloalkyl, aryl, heteroaryl, arylalkyl, heterocyclyl, or heteroarylalkyl, each optionally substituted;
each R 2 is hydrogen;
R 3 , R 4 , R 5 , and R 6 can be the same or different and are individually hydrogen, C 1 -C 6 alkyl, heteroalkyl, halide, —OR 7 , —SR 7 , —N(R 7 ) 2 , or —C(═O)R 8 , each optionally substituted;
each R 7 can be the same or different and is hydrogen, alkyl, heteroalkyl, cycloalkyl, heterocyclyl, haloalkyl, aryl, or heteroaryl, each optionally substituted;
each R 8 can be the same or different and is hydrogen, alkyl, heteroalkyl, cycloalkyl, haloalkyl, heterocyclyl, aryl, heteroaryl, —OH, alkoxy, —NH 2 , alkylamino, —SH, or alkylthiol, each optionally substituted;
m is an integer between 1 and 12, inclusive; and
n is an integer between 1 and 4, inclusive.
2. A composition of claim 1 , wherein the compound of formula (II) comprises the structure of formula (IV):
or a salt, free base, or combination thereof.
3. The composition of claim 2 , wherein the compound of formula (IV) comprises formula (III):
wherein X ⊖ is a counter anion having a charge of (−1), (−2), or (−3).
4. The composition of claim 3 , wherein X ⊖ is halide, phosphate, sulfate, trifluoroacetate, tolunesulfonate, acetate, formate, citric, ascorbate, mesylate (methanesulfonate), or benzoate.
5. The composition of claim 1 , wherein the compound of formula (II) comprises the formula:
or a salt, free base, or combination thereof.
6. The composition of claim 1 , wherein m is 3.
7. The composition of claim 1 , wherein n is 1.
8. The composition of claim 1 , wherein R 1 is
(a) C 1 -C 6 alkyl, haloalkyl, or aryl;
(b) methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, pentyl, or hexyl;
(c) haloalkyl;
(d) CF 3 ;
(e) phenyl, optionally substituted; or
(f) 4-CH 3 Ph, 2,4,6-(CH 3 ) 3 C 6 H 2 , or C 6 H 4 X, wherein X is halide.
9. The composition of claim 1 , wherein m is an integer between 1 and 10, inclusive; or between 1 and 8, inclusive; or between 1 and 6, inclusive.
10. The composition of claim 1 , wherein R 4 , R 5 , and R 6 are hydrogen; and R 3 is halide or Br.
11. The composition of claim 1 , wherein the composition comprises a salt of the compound of formula (II).
12. The composition of claim 11 , wherein the salt is a pharmaceutically acceptable salt.
13. The composition of claim 1 , wherein the compound of formula (II) comprises the structure:
14. The composition of claim 4 , wherein X ⊖ is halide.
15. The composition of claim 3 , wherein X ⊖ is trifluoroacetate.
16. The composition of claim 3 , wherein X ⊖ is mesylate.
17. The composition of claim 3 , wherein X ⊖ is benzoate.